# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate hGH inhibitors

## SUMMARY OF THE INVENTION

- describe isolated polypeptide
- describe composition with S1H peptide
- describe method of inhibiting hGH action
- describe method of treating hGH related disorder
- describe use of synthetic peptide

## DETAILED DESCRIPTION OF THE INVENTION

- provide general understanding of invention scope

### Definitions

- define singular forms
- define "or" and "and/or"
- define "have", "having", "include", "including"
- define "peptide" and "polypeptide"
- define "nucleic acid" and "polynucleotide"
- define "complement" of a nucleic acid
- define "cDNA"
- define "homologous" nucleic acids
- define "variant mimics"
- define "derivative" and "variant"
- define "substitutional variants"
- define "conservative amino acid substitution"
- define "insertional variants"
- define "deletional variants"
- define "covalent derivatives"
- define "features" of polypeptides
- define "surface manifestation"
- define "local conformational shape"
- define "fold"
- define "turn"
- define "loop"
- define "half-loop"
- define "domain" and "half-domain"
- define "site", "termini", and "terminus"

### General Description

- introduce peptide-based mimetic of hGH site 1 helix
- describe application of S1H peptide inhibitor

### Examples

- introduce examples of the present invention
- illustrate preferred embodiments of the invention
- provide essential characteristics of the invention
- describe methods for reagents and chemicals
- outline peptide synthesis procedures
- detail cleavage and purification of peptides
- characterize peptides by MS and analytical HPLC
- describe structural characterization of peptide products
- outline cell culture and hGH treatment procedures
- describe protein extraction and western blotting procedures
- detail ELISA procedures for pSTAT5 levels
- perform statistical analyses of results
- provide figures illustrating hGH bound to dimerized hGHR
- show figures illustrating peptide structures and properties
- show Western blot results
- show ELISA analyses of agonist properties
- show ELISA analyses of antagonist properties
- describe diseases treatable with S1H
- list cancers treatable with S1H
- describe pharmaceutical compositions
- list pharmaceutically acceptable excipients
- describe administration methods
- define pharmaceutical and pharmacologically acceptable
- describe carriers and diluents
- list chemotherapeutic agents
- describe pharmaceutical forms
- describe preservation methods
- describe topical administration
- describe transdermal administration
- describe aerosol administration
- describe dosage determination
- describe packaging and kits

